Kanwaljeet Singh Selected Research

Kanwaljeet Singh Research Topics

3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2022 - 01/2021
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 02/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2018 - 04/2017
1	Bone Marrow Failure Disorders 04/2022
1	Avitaminosis (Vitamin Deficiency) 04/2022
1	Pancytopenia 04/2022
1	Protein S Deficiency (Deficiency, Protein S) 10/2021
1	Protein C Deficiency 10/2021
1	Hyperhomocysteinemia 10/2021
1	Spontaneous Abortion (Miscarriage) 10/2021
1	Activated Protein C Resistance (APC Resistance) 10/2021
1	Thrombophilia 10/2021
1	Febrile Neutropenia 01/2021
1	Hemorrhage 01/2021
1	Infections 01/2021
1	Thalassemia 12/2019
1	Philadelphia Chromosome 04/2019
1	Delta-Beta Thalassemia 10/2018
1	Thrombasthenia (Glanzmann Thrombasthenia) 03/2018

3	Inosine Triphosphate (ITP)IBA 06/2022 - 01/2021
2	factor V LeidenIBA 10/2021 - 02/2017
2	Fetal Hemoglobin (Hemoglobin F)IBA 12/2019 - 10/2018
2	Imatinib Mesylate (Gleevec)FDA Link 10/2018 - 03/2018
1	RHO(D) antibody (anti-D)IBA 06/2022
1	Immunoglobulins (Immunoglobulin)IBA 06/2022
1	Rho(D) Immune Globulin (RhoGAM)IBA 06/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2022
1	Adenosine Monophosphate (AMP)IBA 04/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 04/2022
1	Thrombin FDA Link 10/2021
1	Protein CIBA 10/2021
1	Prothrombin (Factor II)IBA 10/2021
1	Protein SIBA 10/2021
1	HomocysteineIBA 10/2021
1	AnticoagulantsIBA 10/2021
1	Azathioprine (Imuran)FDA LinkGeneric 01/2021
1	bcr-abl Fusion ProteinsIBA 04/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Thromboplastin (Tissue Factor)IBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 04/2017
1	p 230 (p230)IBA 04/2017

2	Therapeutics 04/2022 - 01/2021
1	Splenectomy 01/2021